Back | Next |
home / stock / vstm / vstm message board
Subject | By | Source | When |
---|---|---|---|
Really Good Friday here | Triple nickle | investorshub | 05/26/2023 3:44:18 PM |
WHAT NEWS ?????? | power11 | investorshub | 05/26/2023 3:24:17 PM |
Id be nice waking up to thirty bucks | Triple nickle | investorshub | 05/26/2023 2:39:51 PM |
This kind of news you can skip PHASEIII | shurtha2000 | investorshub | 05/26/2023 2:32:54 PM |
Next week it should run strong. | Tartiaboy | investorshub | 05/26/2023 2:27:02 PM |
This news is very positive | Harbor6460 | investorshub | 05/26/2023 2:25:53 PM |
Peeps see double tops and think sell Just | Triple nickle | investorshub | 05/26/2023 2:16:28 PM |
You would think. | Tartiaboy | investorshub | 05/26/2023 2:10:46 PM |
Break past .52 come on | Triple nickle | investorshub | 05/26/2023 2:09:37 PM |
here we go bulls news is here | Tartiaboy | investorshub | 05/23/2023 9:20:29 PM |
The gaining | catinhat | investorshub | 05/23/2023 3:39:15 PM |
Price trading last trade up | instock58 | investorshub | 05/22/2023 5:16:05 PM |
Price trading | Harbor6460 | investorshub | 05/22/2023 11:05:27 AM |
$VSTM Looks pretty positive | Harbor6460 | investorshub | 05/22/2023 6:34:21 AM |
Insiders are buying options. Time to load imo. | Harbor6460 | investorshub | 05/18/2023 2:46:51 PM |
The now | TommyBoyTrader9460 | investorshub | 05/18/2023 3:44:24 AM |
just the news we needed | DrHarleyboy | investorshub | 05/17/2023 5:21:32 AM |
I'm with you on this one and so | SaltyOne | investorshub | 05/04/2023 12:28:09 AM |
Never seen a board that nobody post wtf. | Harbor6460 | investorshub | 04/28/2023 7:01:23 PM |
whytestocks: $VSTM News Article - Verastem $VSTM Proactive Strategies | whytestocks | investorshangout | 03/13/2023 2:15:49 PM |
News, Short Squeeze, Breakout and More Instantly...
Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced that its management team will participate in a fireside chat at the 2024 RBC Capital Markets Global Healthcare Conference in New York on Tuesday, May 14, 20...
Dr. Hayslip to lead development programs for avutometinib, including Verastem Oncology’s international confirmatory Phase 3 RAMP 301 clinical trial, and advance pipeline assets Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for ...
Findings presented at SGO 2024 show 87% of respondents afraid of making long-term plans due to the possibility of a shorter life expectancy 84% say dealing with treatment side effects has negatively impacted their emotional well-being, and 94% worry about LGSOC returning despite treatment...